Is Aegerion Pharmaceuticals, Inc. (AEGR) Going to Burn These Hedge Funds?

Page 1 of 2

To the average investor, there are dozens of gauges market participants can use to watch publicly traded companies. Some of the most under-the-radar are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the top investment managers can beat the S&P 500 by a healthy amount (see just how much).

Just as necessary, optimistic insider trading sentiment is a second way to look at the investments you’re interested in. Just as you’d expect, there are a number of reasons for an executive to get rid of shares of his or her company, but just one, very obvious reason why they would behave bullishly. Plenty of academic studies have demonstrated the valuable potential of this method if “monkeys” understand where to look (learn more here).

Thus, let’s study the newest info about Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR).

Hedge fund activity in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)

In preparation for the third quarter, a total of 26 of the hedge funds we track held long positions in this stock, a change of 30% from the first quarter. With hedgies’ capital changing hands, there exists a few notable hedge fund managers who were upping their holdings considerably.

Aegerion PharmaceuticalsAccording to our 13F database, Joseph Edelman’s Perceptive Advisors had the largest position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), worth close to $226.3 million, comprising 22.8% of its total 13F portfolio. Sitting at the No. 2 spot is Mark Kingdon of Kingdon Capital, with a $64.9 million call position; the fund has 3.8% of its 13F portfolio invested in the stock. Some other hedge funds with similar optimism include Julian Baker and Felix Baker’s Baker Bros. Advisors, Mark Kingdon’s Kingdon Capital and Christopher Medlock James’s Partner Fund Management.

As one would understandably expect, particular hedge funds have jumped into Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) headfirst. Perceptive Advisors, managed by Joseph Edelman, established the largest position in Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). Perceptive Advisors had 226.3 million invested in the company at the end of the quarter. Mark Kingdon’s Kingdon Capital also initiated a $64.9 million position during the quarter. The other funds with brand new AEGR positions are Julian Baker and Felix Baker’s Baker Bros. Advisors, Mark Kingdon’s Kingdon Capital, and Christopher MedlockáJames’s Partner Fund Management.

How have insiders been trading Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR)?

Insider buying is at its handiest when the company in question has experienced transactions within the past six months. Over the latest half-year time frame, Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) has seen zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

We’ll also take a look at the relationship between both of these indicators in other stocks similar to Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR). These stocks are Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Intercept Pharmaceuticals Inc (NASDAQ:ICPT), Neurocrine Biosciences, Inc. (NASDAQ:NBIX), Pacira Pharmaceuticals Inc (NASDAQ:PCRX), and Impax Laboratories Inc (NASDAQ:IPXL). This group of stocks belong to the drug manufacturers – major industry and their market caps match AEGR’s market cap.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months Click to see monthly returns in table format!

Lists

6 Movies That You Should Watch to Better Understand The Cold War

Top 15 Best Paying Jobs for Women in 2014

Top 6 Things Rich People Do Differently Every Day

5 Retirement Mistakes To Avoid (and Einstein’s Famous Quote)

11 Smartest People in the World

6 Films About the Financial World You Need To Watch (While “The Wolf” is Not Around)

Warren Buffett and Billionaires Are Crazy About These 7 Stocks

The Top 10 States With Fastest Internet Speeds

10 Best Places to Visit in USA in August

Top 10 Cities to Visit Before You Die

Top 10 Genetically Modified Food In the US

15 Highest Grossing Movies Opening Weekend

5 Best Poker Books For Beginners

10 Strategies Hedge Funds Use to Make Huge Returns

Top 10 Fast Food Franchises to Buy

10 Best Places to Visit in Canada

Best Summer Jobs for Teachers

10 Youngest Hedge Fund Billionaires

Top 10 One Hit Wonders of the 90s

Fastest Growing Cities In America

Top 10 U.S. Cities for Freelancers

Top 9 Most Popular Free iPhone Apps

Top 10 Least Expensive Private Business Schools in the US

Top 15 Most Expensive Countries in the World – 2014

Top 6 Tax Scams and How to Protect Yourself

Top Businesses to Invest In

Top 5 Things You Might Be Doing Wrong With Your Business

Top 5 Strategic Technology Trends in 2014

Top Rags to Riches Stories

Parenting Behavior That Promotes Future Leaders

Top 5 Mistakes Made by Small Businesses

Top 5 Most Common and Potentially Devastating Financial Blunders

Top 5 Highest Paying Jobs for Web Designers

Top 6 Most Respected Professions that Also Pay Well

Top 5 Pitfalls Investors Should Avoid

Top 6 Lawyers and Policy Makers Under 30

Top 6 New Year’s Resolutions for Entrepreneurs

Top 7 Locations to Check in on Facebook

Top 5 Mistakes made by Rookie eBay Sellers

Top 7 eBook Publishers in 2013

Top 6 Health Industry Trends in 2014

5 Lessons for Entrepreneurs from Seth Godin

Top 5 Success Tips from Jordan Belfort – the Wolf of Wall Street

Best Master’s in Finance Degree Programs

Top 6 Earning Celebrities Over 50

The most expensive sports to play

Top 7 Earning Celebrities Under 25

Best 7 Online Courses to Take: Free Finance MOOCs

Top 6 Bad Habits that Promote Failure

20 Most Valuable Soccer Teams in the World in 2013

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!